Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study

BACKGROUND: We evaluated the safety and efficacy of induction chemotherapy with bevacizumab followed by maintenance chemotherapy with bevacizumab for advanced non-small cell lung cancer (NSCLC) in this multicenter phase II study. METHODS: Chemotherapy-naïve patient with stage IIIB–IV or recurrent no...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsutani, Yasuhiro, Miyata, Yoshihiro, Masuda, Takeshi, Fujitaka, Kazunori, Doi, Mihoko, Awaya, Yoshikazu, Kuyama, Shoichi, Kitaguchi, Soichi, Ueda, Kazuhiro, Hattori, Noboru, Okada, Morihito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288966/
https://www.ncbi.nlm.nih.gov/pubmed/30526545
http://dx.doi.org/10.1186/s12885-018-5146-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288966/
https://www.ncbi.nlm.nih.gov/pubmed/30526545
http://dx.doi.org/10.1186/s12885-018-5146-3

Ejemplares similares